Summary: LEAP-2 is a ghrelin antagonist with an anorexigenic drive. This study investigates the evolution of plasma ghrelin and LEAP-2 concentrations in 29 patients with anorexia nervosa (AN) before and after refeeding and compares it to physiological adaptations during fasting in healthy controls or to mouse model of chronic food restriction and refeeding. Acute and chronic food rest... https://www.hindigyanvishv.com/best-flash-CoQ-Clear-100-Ubiquinol-60-Softgels-Citrus-deal-zone/